F 0658
Ensure services provided by the nursing facility meet professional standards of quality.
Level of Harm - Minimal harm
or potential for actual harm
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on
observation, interview and record review, the facility failed to meet professional standards of quality, for one
of three sampled residents (Resident 1) when Resident 1 did not have duloxetine (medication for
depression) available for three days and licensed nurses did not follow up with pharmacy to check the order
status.
Residents Affected - Few
This failure placed Resident 1 at risk to experience anxiety, irritability, difficulty in sleeping, and possibly
nightmares.
Findings:
During on observation on [DATE] at 5:33 p.m. in Resident 1 ' s room, Resident 1 was seated in her
wheelchair. Resident 1 stated she has not received duloxetine for three days because the facility ran out of
her medication. Resident 1 stated the medication was working well and since she stopped taking the
medication, she experienced nightmares.
During a review of Resident 1's Face Sheet (FS, a document with demographic, personal and medical
information) undated, the FS indicated Resident 1 had diagnoses which included anxiety and major
depression.
During a review of Resident 1's Minimum Data Set (MDS - a resident assessment tool used to identify
resident cognitive and physical function) assessment dated [DATE], the MDS indicated Resident 1's Brief
Interview for Mental Status (BIMS -assessment of cognitive status for memory and judgment) assessment
score was 15 out of 15 (a score of 13-15 indicates cognitively intact, 08-12 indicates moderately impaired,
and 00-07 indicates severe impairment). The BIMS assessment indicated Resident 1 was cognitively intact.
During a review of Resident 1's Physician Order(PO) dated [DATE], the PO indicated, . 20 MG
[milligram-unit of measure] (Duloxetine) Give 2 capsule by mouth two times a day for irritability, general
discontent .
During a concurrent interview and record review on [DATE] at 6:08 p.m. with Licensed Vocational Nurse
(LVN) 1, Resident 1 ' s Medication Administration Record (MAR) dated 12/2023 was reviewed. The MAR
indicated, duloxetine was unavailable from [DATE] - [DATE]. LVN 1 stated there was no documentation in
Resident 1 ' s clinical record to indicate that pharmacy was contacted to ensure the medication order went
through. LVN 1 stated if pharmacy was notified, they would have received the medication the same day.
LVN 1 stated the Licensed Nurse (LN) should have ensured the medication was ordered timely to prevent
the medication from running out.
(continued on next page)
Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other
safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the
date of survey whether or not a plan of correction is provided. For nursing homes, the above findings and plans of correction are disclosable 14 days following the date
these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation.
LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER
REPRESENTATIVE'S SIGNATURE
TITLE
(X6) DATE
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Facility ID:
If continuation sheet
Page 1 of 2
Event ID:
055839
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
055839
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
12/19/2023
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
San Luis Care Center
709 N Street
Newman, CA 95360
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0658
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
During an interview on [DATE] at 7:06 p.m. with LVN 2, LVN 2 stated she was currently the assigned nurse
for Resident 1. LVN 2 stated she did not administer duloxetine because it was unavailable. LVN 2 stated she
did not call pharmacy to check on the order status but should have. LVN 2 stated Resident 1 should have
received the medication to prevent her from becoming irritable.
During a telephone interview on [DATE] at 9:33 a.m., with Pharmacy Consultant (PC), PC stated the side
effect of missing doses of duloxetine was potentially feeling depressed and irritable. PC stated the facility
should have ordered the medication ahead of time to prevent missing doses.
During a telephone interview on [DATE] at 10:00 a.m. with LVN 3, LVN 3 stated the prescription for
duloxetine was expired and needed to be re-ordered. LVN 3 stated LN ' s should re-order medication when
there is three day supply left. LVN 3 stated if there was a follow up call to pharmacy it would be documented
in the nurses notes.
During a concurrent telephone interview and record review on [DATE] at 11:30 a.m. with the Director of
Nursing (DON), the facility policy titled Reordering, Changing, and Discontinuing Orders dated [DATE] was
reviewed. The policy indicated, .Facility staff should review the transmitted re-orders for status and potential
issues and Pharmacy response . The DON stated when medication supply is less than three days the LN
should call the physician and pharmacy to follow up to prevent delay. The DON stated LN ' s should
document their conversation to ensure follow up was done.
During a review of MedlinePlus Professional Reference titled, Duloxetine dated [DATE], (found at
https://medlineplus.gov/druginfo/meds/a604030.html#how) indicated, .If you suddenly stop taking
duloxetine, you may experience withdrawal symptoms such as nausea; vomiting; diarrhea; anxiety;
dizziness; tiredness; headache; pain, burning, numbness, or tingling in the hands or feet; irritability; difficulty
falling asleep or staying asleep; sweating; and nightmares .
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
055839
If continuation sheet
Page 2 of 2